PlainRecalls
FDA Devices Moderate Class II Terminated

CD79b PE (ASR) , Catalog number 335816 ; Hematology: The CD79b antibody recognizes an epitope on the extracellular domain of a 3640 kilodalton (kDa) type I membrane glycoprotein. Immunoglobulin (Ig) antigen receptors are composed of a non-covalently associated complex of Ig and two other proteins, Iga and Igb, which have been designated as CD79a and CD79b, respectively. antigen

Reported: October 26, 2016 Initiated: September 21, 2016 #Z-0128-2017

Product Description

CD79b PE (ASR) , Catalog number 335816 ; Hematology: The CD79b antibody recognizes an epitope on the extracellular domain of a 3640 kilodalton (kDa) type I membrane glycoprotein. Immunoglobulin (Ig) antigen receptors are composed of a non-covalently associated complex of Ig and two other proteins, Iga and Igb, which have been designated as CD79a and CD79b, respectively. antigen

Reason for Recall

CD79b (SN8) PE is contaminated with a FITC conjugate of unknown antigenic specificity

Details

Units Affected
14 units
Distribution
Nationwide Distribution to CA, MN, OH and TX.
Location
San Jose, CA

Frequently Asked Questions

What product was recalled?
CD79b PE (ASR) , Catalog number 335816 ; Hematology: The CD79b antibody recognizes an epitope on the extracellular domain of a 3640 kilodalton (kDa) type I membrane glycoprotein. Immunoglobulin (Ig) antigen receptors are composed of a non-covalently associated complex of Ig and two other proteins, Iga and Igb, which have been designated as CD79a and CD79b, respectively. antigen. Recalled by Becton, Dickinson and Company, BD Biosciences. Units affected: 14 units.
Why was this product recalled?
CD79b (SN8) PE is contaminated with a FITC conjugate of unknown antigenic specificity
Which agency issued this recall?
This recall was issued by the FDA Devices on October 26, 2016. Severity: Moderate. Recall number: Z-0128-2017.